Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1605341000001118 | Acalabrutinib 100mg capsules 60 capsule | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1605351000001115 | Acalabrutinib 100mg capsules 60 capsule (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Calquence 100mg capsules (Imported (United States)) 60 capsule | Is a | True | Acalabrutinib 100mg capsules 60 capsule | Inferred relationship | Existential restriction modifier | |
Calquence 100mg capsules (AstraZeneca UK Ltd) 60 capsule 10 x 6 capsules | Is a | True | Acalabrutinib 100mg capsules 60 capsule | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets